首页> 外国专利> THE COMPONENT PROTEIN OF AMILOID P DE SERERO (SAP, SAMP) AS A MARKER OF FORECAST AND DIAGNOSIS FOR THE PRENATAL DIAGNOSIS OF TRISOMY 21 (DOWN SYNDROME).

THE COMPONENT PROTEIN OF AMILOID P DE SERERO (SAP, SAMP) AS A MARKER OF FORECAST AND DIAGNOSIS FOR THE PRENATAL DIAGNOSIS OF TRISOMY 21 (DOWN SYNDROME).

机译:酰胺蛋白P SERERO(SAP,SAMP)的成分蛋白,可预测和诊断三体21的早产儿诊断(唐氏综合症)。

摘要

A method for prognosis and / or diagnosis of trisomy 21 (Down syndrome) in fetuses that includes: a. Quantitative detection of the serum amyloid P protein component (SAP, SAMP, Swiss Prot No: P02743) in peripheral blood, serum and / or plasma of a pregnant woman, and b. the comparison of the quantitative value of that protein obtained in phase (a) with the quantitative value of that protein in the same biological fluid of women carrying chromosomally normal fetuses. C. the prognosis and / or diagnosis is positive if the quantitative value of the serum amyloid component protein P (SAP, SAMP, Swiss Prot No: P02743), is greater than the qualitative value of that protein in the same biological fluid of carrier women of chromosomally normal fetuses.
机译:一种胎儿21三体综合征(唐氏综合症)的预后和/或诊断方法,包括:a。定量检测孕妇外周血,血清和/或血浆中的血清淀粉样蛋白P蛋白成分(SAP,SAMP,瑞士专利号:P02743),以及b。比较阶段(a)中获得的蛋白质的定量值与携带染色体正常胎儿的妇女在相同生物液中的蛋白质的定量值。 C.如果血清淀粉样蛋白成分蛋白P(SAP,SAMP,Swiss Prot No:P02743)的定量值大于该蛋白在携带者妇女相同生物液中的定性值,则预后和/或诊断为阳性染色体正常的胎儿。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号